Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy - Concepedia

Concepedia

Publication | Open Access

Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy

DOI Full Paper Access

676

Citations

47

References

2019

Year

Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, Dennie T. Frederick, Jennifer A. Lo, David E. Fisher, Gordon J. Freeman, Genevieve M. Boland, Andrew D. Luster

Tumor BiologyOncologyAnti-pd-1 TherapyCxcr3 Chemokine SystemMedicineImmunologyImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentIntratumoral ActivityImmunotherapyPharmacologyTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1

Page 1